首站-论文投稿智能助手
典型文献
Small molecules for combating multidrug-resistant superbug Candida auris infections
文献摘要:
Candida auris is emerging as a major global threat to human health.C.auris infections are associated with high mortality due to intrinsic multi-drug resistance.Currently,therapeutic options for the treatment of C.auris infections are rather limited.We aim to provide a comprehensive review of current strategies,drug candidates,and lead compounds in the discovery and development of novel therapeutic agents against C.auris.The drug resistance profiles and mechanisms are briefly summarized.The struc-tures and activities of clinical candidates,drug combinations,antifungal chemosensitizers,repositioned drugs,new targets,and new types of compounds will be illustrated in detail,and perspectives for guiding future research will be provided.We hope that this review will be helpful to prompting the drug devel-opment process to combat this fungal pathogen.
文献关键词:
作者姓名:
Jie Tu;Na Liu;Yahui Huang;Wanzhen Yang;Chunquan Sheng
作者机构:
School of Pharmacy,Second Military Medical University,Shanghai 200433,China
引用格式:
[1]Jie Tu;Na Liu;Yahui Huang;Wanzhen Yang;Chunquan Sheng-.Small molecules for combating multidrug-resistant superbug Candida auris infections)[J].药学学报(英文版),2022(11):4056-4074
A类:
superbug,auris,chemosensitizers
B类:
Small,molecules,combating,multidrug,resistant,Candida,infections,emerging,major,global,threat,human,health,are,associated,high,mortality,due,intrinsic,resistance,Currently,therapeutic,options,treatment,rather,limited,We,aim,comprehensive,review,current,strategies,candidates,lead,compounds,discovery,development,novel,agents,against,profiles,mechanisms,briefly,summarized,struc,tures,activities,clinical,combinations,antifungal,repositioned,drugs,new,targets,types,will,be,illustrated,detail,perspectives,guiding,future,research,provided,hope,that,this,helpful,prompting,process,pathogen
AB值:
0.564739
相似文献
Discovery of a novel DDRs kinase inhibitor XBLJ-13 for the treatment of idiopathic pulmonary fibrosis
Ying Dong;Bi-xi Tang;Qi Wang;Li-wei Zhou;Cong Li;Xuan Zhang;Dan-dan Sun;Xin Sun;Xue-mei Zhang;Bing Xiong;Jia Li;Hong Shi;Dan-qi Chen;Yi Zang-State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Department of Pharmacology,School of Pharmacy,Fudan University,Shanghai 201203,China;Department of Medicinal Chemistry,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Center for Supramolecular Chemistry and Catalysis and Department of Chemistry,College of Sciences,Shanghai University,Shanghai 200444,China;Schoolof Chinese Materia Medica,Nanjing University of Chinese Medicine,Nanjing 210023,China;Schoolof Pharmacy,Henan University,Kaifeng 475004,China;Open Studio for Druggability Research of Marine Natural Products,Pilot National Laboratory for Marine Science and Technology(Qingdao),Qingdao 266237,China;School of Pharmaceutical Science and Technology,Hangzhou Institute for Advanced Study,UCAS,Hangzhou 310024,China;Department of Anesthesiology of Shanghai Pulmonary Hospital,School of medicine,Tongji University,Shanghai 200433,China
Acquisition of taxane resistance by p53 inactivation in ovarian cancer cells
Changfa Shu;Xi Zheng;Alafate Wuhafu;Danielle Cicka;Sean Doyle;Qiankun Niu;Dacheng Fan;Kun Qian;Andrey A.Ivanov;Yuhong Du;Xiulei Mo;Haian Fu-Department of Pharmacology and Chemical Biology,Emory University School of Medicine,Atlanta,GA 30322,USA;Department of Gynecology and Obstetrics,The Third Xiangya Hospital of Central South University,Changsha 410013,China;Cancer Institute,the Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310052,China;The First Affiliated Hospital,Medical School of Xi'an Jiaotong University,Xi'an 710061,China;Emory Chemical Biology Discovery Center,Emory University School of Medicine,Atlanta,GA 30322,USA;Department of Hematology and Medical Oncology and Winship Cancer Institute,Emory University,Atlanta,GA 30322,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。